Cole Douglas G. - Insider Non-Derivative Transactions at Denali Therapeutics Inc. (DNLI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 1, 2023, Cole Douglas G.'s relationship to Denali Therapeutics Inc. (DNLI) is Director, and currently has 26,564 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other DNLI insiders.
Data Source: SEC.
Cole Douglas G. - Insider Non-Derivative Transactions at DNLI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 2, 2023 | Acquisition -- (Common Stock) | 4216 | 0 | 26564 |